Key players such as University of Southern California and others are developing therapies to enhance treatment modalities in the Drug Hypersensitivity market

October 28 00:58 2021
Key players such as University of Southern California and others are developing therapies to enhance treatment modalities in the Drug Hypersensitivity market
Drug Hypersensitivity Market
The market dynamics of Drug Hypersensitivity are expected to change as drug utilization of various drugs increases.

DelveInsight’s Drug Hypersensitivity market report thoroughly explains the Drug Hypersensitivity historical and forecasted epidemiology and the Drug Hypersensitivity market trends in the 7MM. The Drug Hypersensitivity report also analyzes the current Drug Hypersensitivity treatment algorithms, market dynamics, and unmet medical needs.

Key Takeaways from the Drug Hypersensitivity Market Report

  • According to a study conducted in the United States by Doa et al. (2018), nonsteroidal anti-inflammatory drug (NSAID)-induced hypersensitivity reactions are classified as either cross-reactive or selective by the European Network on Drug Allergy (ENDA).

  • According to a study conducted in France by Landry et al. (2019), a total of 9250 patients were investigated, with 1819 testing positive for at least one drug.

  • Key players involved in improving the Drug Hypersensitivity treatment landscape include the University of Southern California and others.

  • Key pipeline Drug Hypersensitivity therapy includes Cyclosporine and others.

  • The investigators at the University of Southern California are undertaking an early Phase I trial to establish the efficacy of the two medicines (Cyclosporine vs. Steroids) with specific objectives in mind so that they can study the safety of these two therapies in DRES’s patients.

Request for the sample to know more @ Drug Hypersensitivity Market Research

Drug Hypersensitivity Overview

Drug Hypersensitivity is an immune-mediated reaction to a drug. Symptoms range from mild to severe and include rash, anaphylaxis, and serum sickness. Drug Hypersensitivity Reactions (DHR) are allergic, exaggerated pharmacologic, and pseudo allergic reactions to medications caused by an enhanced immunologic or inflammatory response.

Drug Hypersensitivity Epidemiology Segmentation

The Drug Hypersensitivity report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Total Number of Cases based on the Utilization of Various Classes of Drugs

  • Drug Hypersensitivity Total Number of Cases

Drug Hypersensitivity Treatment Landscape

Drug Hypersensitivity is primarily treated with drug discontinuation, supportive treatment (e.g., antihistamines, corticosteroids, epinephrine), and, in some cases, desensitization. 

Drug Hypersensitivity Market Outlook

The market dynamics of Drug Hypersensitivity are expected to change as drug utilization of various drugs increases. Thus with the anticipated increase in patients, the Drug Hypersensitivity market will experience an upsurge.

Get a detailed analysis of the market @ Drug Hypersensitivity Market Analysis

Drug Hypersensitivity Pipeline Therapies and Key Companies 

  • Cyclosporine: University of Southern California

Table of Contents 

1.

Report Introduction

2.

Executive Summary of Drug Hypersensitivity

3.

Drug Hypersensitivity Market Share at a Glance

4.

Drug Hypersensitivity Disease Background and Overview

5.

Drug Hypersensitivity Patient Journey

6.

Drug Hypersensitivity Epidemiology and Patient Population

7.

Country Wise: Epidemiology of Drug Hypersensitivity 

8.

Drug Hypersensitivity Current Treatment and Medical Practices

9.

Current Unmet Needs of Drug Hypersensitivity

10.

Market Size of Drug Hypersensitivity 

11.

Region-Wise Market size of Drug Hypersensitivity 

12.

Drug Hypersensitivity Market Drivers

13.

Drug Hypersensitivity Market Barriers

14.

SWOT Analysis

15.

Drug Hypersensitivity Reimbursement and Market Access

16.

KOL Views

17.

Appendix

18.

Report Methodology

19.

DelveInsight Capabilities

20.

Disclaimer

21.

About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Antibody Drug Conjugate Market

DelveInsight’s “Antibody Drug Conjugate- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Antibody Drug Conjugate, historical and forecasted epidemiology, as well as the Antibody Drug Conjugate market trends in the 7MM.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/